Cui Jingrong Jean
Insider CIK 1772259 · TPTX Chief Scientific Officer, Director · BLSM President and CEO, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-10 | 124,779 | — | $0 | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-10 | 113,435 | — | $0 | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,600,682 | — | $0 | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-10 | 113,435 | — | $0 | 1,714,117 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-10 | 124,779 | — | $0 | 124,779 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-10 | 1,600,682 | — | $0 | 1,600,682 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-10 | 124,779 | — | — | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-10 | 113,435 | — | — | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,600,682 | — | — | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-10 | 124,779 | — | — | 124,779 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-10 | 113,435 | — | — | 1,714,117 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-10 | 1,600,682 | — | — | 1,600,682 | SEC↗ |
| BLSM BlossomHill Therapeutics, | A Award deriv | 2026-08-06 | 2026-08-10 | 676,205 | — | $0 | 676,205 | SEC↗ |
| BLSM BlossomHill Therapeutics, | A Award deriv | 2026-08-06 | 2026-08-10 | 676,205 | — | $0 | 676,205 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-09 | 2020-06-10 | 4,515 | $65.80 | $297.1K | 543,268 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-09 | 2020-06-10 | 2,585 | $66.60 | $172.2K | 540,683 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-09 | 2020-06-10 | 300 | $67.48 | $20.2K | 540,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-09 | 2020-06-10 | 1,688 | $64.82 | $109.4K | 547,783 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-09 | 2020-06-10 | 412 | $63.80 | $26.3K | 549,471 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-08 | 2020-06-08 | 5,961 | $63.92 | $381.0K | 549,883 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-08 | 2020-06-08 | 10,667 | $63.36 | $675.9K | 555,844 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-08 | 2020-06-08 | 1,872 | $62.50 | $117.0K | 566,511 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-05 | 2020-06-08 | 1,300 | $65.66 | $85.4K | 568,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-05 | 2020-06-08 | 4,671 | $65.03 | $303.8K | 569,683 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-05 | 2020-06-08 | 8,927 | $64.04 | $571.7K | 574,354 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-05 | 2020-06-08 | 3,602 | $63.04 | $227.1K | 583,281 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-04 | 2020-06-08 | 828 | $69.54 | $57.6K | 586,883 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-04 | 2020-06-08 | 2,072 | $68.62 | $142.2K | 587,711 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-04 | 2020-06-08 | 1,800 | $67.52 | $121.5K | 589,783 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-04 | 2020-06-08 | 600 | $65.81 | $39.5K | 591,583 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-04 | 2020-06-08 | 4,012 | $64.67 | $259.5K | 592,183 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-04 | 2020-06-08 | 3,688 | $63.88 | $235.6K | 596,195 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-04 | 2020-06-08 | 3,600 | $62.70 | $225.7K | 599,883 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-06-04 | 2020-06-08 | 1,900 | $61.76 | $117.3K | 603,483 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-21 | 2020-05-21 | 6,900 | $59.64 | $411.5K | 605,483 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-21 | 2020-05-21 | 100 | $60.34 | $6.0K | 605,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-20 | 2020-05-21 | 1,400 | $60.98 | $85.4K | 612,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-20 | 2020-05-21 | 5,100 | $60.03 | $306.2K | 613,783 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-20 | 2020-05-21 | 500 | $59.04 | $29.5K | 618,883 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-19 | 2020-05-21 | 400 | $58.94 | $23.6K | 619,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-19 | 2020-05-21 | 1,200 | $56.33 | $67.6K | 625,183 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-19 | 2020-05-21 | 3,000 | $58.36 | $175.1K | 619,783 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-19 | 2020-05-21 | 2,400 | $57.44 | $137.9K | 622,783 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-08 | 2020-05-12 | 730 | $52.53 | $38.3K | 637,153 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-08 | 2020-05-12 | 5,920 | $53.49 | $316.7K | 631,233 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-08 | 2020-05-12 | 4,750 | $54.49 | $258.8K | 626,483 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-08 | 2020-05-12 | 100 | $55.16 | $5.5K | 626,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-07 | 2020-05-07 | 11,864 | $53.05 | $629.4K | 639,213 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-07 | 2020-05-07 | 5,306 | $52.22 | $277.1K | 651,077 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-07 | 2020-05-07 | 1,330 | $53.70 | $71.4K | 637,883 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-06 | 2020-05-07 | 6,072 | $52.54 | $319.0K | 668,811 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-06 | 2020-05-07 | 12,428 | $53.13 | $660.3K | 656,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-05 | 2020-05-07 | 5,784 | $54.67 | $316.2K | 674,883 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-05 | 2020-05-07 | 8,718 | $54.04 | $471.1K | 680,667 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-05-05 | 2020-05-07 | 3,998 | $53.05 | $212.1K | 689,385 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-24 | 2020-04-24 | 3,213 | $50.60 | $162.6K | 697,170 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-24 | 2020-04-24 | 3,487 | $51.31 | $178.9K | 693,683 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-24 | 2020-04-24 | 300 | $51.98 | $15.6K | 693,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-23 | 2020-04-24 | 1,200 | $53.22 | $63.9K | 700,783 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-23 | 2020-04-24 | 400 | $53.82 | $21.5K | 700,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-23 | 2020-04-24 | 2,200 | $52.16 | $114.8K | 701,983 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-23 | 2020-04-24 | 3,200 | $51.02 | $163.3K | 704,183 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-22 | 2020-04-24 | 5,700 | $51.64 | $294.3K | 708,683 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-22 | 2020-04-24 | 1,300 | $52.41 | $68.1K | 707,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-13 | 2020-04-13 | 200 | $49.87 | $10.0K | 714,691 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-13 | 2020-04-13 | 200 | $48.44 | $9.7K | 714,891 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-13 | 2020-04-13 | 308 | $51.22 | $15.8K | 714,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-09 | 2020-04-13 | 1,892 | $48.75 | $92.2K | 715,091 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-09 | 2020-04-13 | 5,982 | $46.81 | $280.0K | 720,609 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-09 | 2020-04-13 | 3,626 | $47.82 | $173.4K | 716,983 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-08 | 2020-04-08 | 100 | $47.23 | $4.7K | 726,591 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-08 | 2020-04-08 | 12,106 | $46.43 | $562.1K | 726,691 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-08 | 2020-04-08 | 6,294 | $45.89 | $288.8K | 738,797 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-07 | 2020-04-08 | 4,500 | $43.69 | $196.6K | 759,091 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-07 | 2020-04-08 | 5,900 | $45.63 | $269.2K | 745,091 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-07 | 2020-04-08 | 8,100 | $44.96 | $364.2K | 750,991 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-06 | 2020-04-08 | 11,212 | $43.72 | $490.2K | 766,781 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-06 | 2020-04-08 | 2,998 | $42.61 | $127.7K | 777,993 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-06 | 2020-04-08 | 1,100 | $41.46 | $45.6K | 780,991 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-06 | 2020-04-08 | 300 | $45.13 | $13.5K | 763,591 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-04-06 | 2020-04-08 | 2,890 | $44.22 | $127.8K | 763,891 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-26 | 2020-03-27 | 200 | $48.06 | $9.6K | 782,091 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-26 | 2020-03-27 | 6,600 | $45.37 | $299.4K | 786,991 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-26 | 2020-03-27 | 3,052 | $46.55 | $142.1K | 783,939 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-26 | 2020-03-27 | 1,648 | $47.48 | $78.2K | 782,291 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-25 | 2020-03-25 | 2,200 | $46.50 | $102.3K | 793,791 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-25 | 2020-03-25 | 13,292 | $45.35 | $602.8K | 795,991 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-25 | 2020-03-25 | 2,100 | $44.56 | $93.6K | 809,283 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-25 | 2020-03-25 | 200 | $47.11 | $9.4K | 793,591 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-24 | 2020-03-25 | 400 | $43.58 | $17.4K | 811,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-24 | 2020-03-25 | 2,100 | $42.72 | $89.7K | 811,783 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-24 | 2020-03-25 | 3,200 | $41.73 | $133.5K | 813,883 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-24 | 2020-03-25 | 1,300 | $40.75 | $53.0K | 817,083 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-23 | 2020-03-25 | 3,000 | $38.77 | $116.3K | 819,583 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-23 | 2020-03-25 | 1,900 | $37.88 | $72.0K | 822,583 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-23 | 2020-03-25 | 900 | $36.52 | $32.9K | 824,483 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-23 | 2020-03-25 | 1,200 | $39.63 | $47.6K | 818,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-12 | 2020-03-12 | 701 | $37.91 | $26.6K | 825,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-12 | 2020-03-12 | 1,878 | $36.94 | $69.4K | 826,084 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-12 | 2020-03-12 | 1,821 | $36.07 | $65.7K | 827,962 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-12 | 2020-03-12 | 2,600 | $34.96 | $90.9K | 829,783 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-11 | 2020-03-12 | 3,200 | $42.86 | $137.2K | 833,783 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-11 | 2020-03-12 | 1,400 | $43.72 | $61.2K | 832,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-11 | 2020-03-12 | 2,400 | $41.50 | $99.6K | 836,983 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-11 | 2020-03-12 | 6,800 | $40.61 | $276.1K | 839,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-11 | 2020-03-12 | 4,700 | $40.02 | $188.1K | 846,183 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-10 | 2020-03-12 | 7,100 | $41.61 | $295.4K | 862,283 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-10 | 2020-03-12 | 3,400 | $43.33 | $147.3K | 850,883 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-03-10 | 2020-03-12 | 8,000 | $42.42 | $339.4K | 854,283 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-26 | 2020-02-26 | 4,400 | $51.18 | $225.2K | 871,983 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-26 | 2020-02-26 | 2,300 | $51.76 | $119.0K | 869,683 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-26 | 2020-02-26 | 300 | $52.58 | $15.8K | 869,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-25 | 2020-02-26 | 3,525 | $50.78 | $179.0K | 879,858 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-25 | 2020-02-26 | 2,175 | $51.37 | $111.7K | 877,683 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-25 | 2020-02-26 | 600 | $53.46 | $32.1K | 876,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-25 | 2020-02-26 | 700 | $52.39 | $36.7K | 876,983 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-24 | 2020-02-26 | 6,000 | $53.62 | $321.7K | 884,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-24 | 2020-02-26 | 1,000 | $54.21 | $54.2K | 883,383 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-13 | 2020-02-14 | 100 | $63.07 | $6.3K | 781,219 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-13 | 2020-02-14 | 200 | $59.83 | $12.0K | 792,519 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-13 | 2020-02-14 | 2,400 | $60.70 | $145.7K | 790,119 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-13 | 2020-02-14 | 8,800 | $62.18 | $547.2K | 781,319 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-12 | 2020-02-12 | 12,400 | $66.19 | $820.8K | 793,019 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-12 | 2020-02-12 | 5,800 | $65.31 | $378.8K | 805,419 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-12 | 2020-02-12 | 300 | $66.80 | $20.0K | 792,719 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-11 | 2020-02-12 | 4,250 | $63.88 | $271.5K | 811,219 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-11 | 2020-02-12 | 14,250 | $63.03 | $898.2K | 815,469 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-10 | 2020-02-12 | 9,249 | $63.14 | $584.0K | 829,719 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-02-10 | 2020-02-12 | 9,251 | $62.75 | $580.5K | 838,968 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-29 | 2020-01-29 | 3,399 | $58.39 | $198.5K | 851,820 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-29 | 2020-01-29 | 3,501 | $59.03 | $206.7K | 848,319 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-29 | 2020-01-29 | 100 | $59.72 | $6.0K | 848,219 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-28 | 2020-01-29 | 4,068 | $58.18 | $236.7K | 858,151 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-28 | 2020-01-29 | 2,932 | $58.62 | $171.9K | 855,219 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-27 | 2020-01-29 | 1,601 | $58.40 | $93.5K | 862,219 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-27 | 2020-01-29 | 1,599 | $56.82 | $90.9K | 867,620 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-27 | 2020-01-29 | 3,800 | $57.71 | $219.3K | 863,820 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-15 | 2020-01-17 | 9,900 | $53.03 | $525.0K | 870,819 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-15 | 2020-01-17 | 1,600 | $53.66 | $85.9K | 869,219 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-14 | 2020-01-14 | 3,390 | $52.44 | $177.8K | 895,829 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-14 | 2020-01-14 | 10,101 | $54.06 | $546.1K | 880,719 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-14 | 2020-01-14 | 5,009 | $53.30 | $267.0K | 890,820 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-13 | 2020-01-14 | 400 | $54.21 | $21.7K | 899,219 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-13 | 2020-01-14 | 10,194 | $53.11 | $541.4K | 899,619 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-13 | 2020-01-14 | 7,906 | $52.49 | $415.0K | 909,813 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-10 | 2020-01-14 | 1,734 | $58.83 | $102.0K | 917,719 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-10 | 2020-01-14 | 10,525 | $57.95 | $609.9K | 920,744 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-10 | 2020-01-14 | 4,250 | $56.79 | $241.4K | 931,269 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-10 | 2020-01-14 | 400 | $55.75 | $22.3K | 935,519 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-10 | 2020-01-14 | 300 | $54.00 | $16.2K | 935,919 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2020-01-10 | 2020-01-14 | 1,291 | $58.38 | $75.4K | 919,453 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2020-01-06 | 2020-01-08 | 55,000 | — | $0 | 55,000 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2019-12-30 | 2020-02-26 | 16,864 | — | $0 | 141,519 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2019-12-30 | 2020-02-26 | 16,864 | $5.12 | $86.3K | 890,383 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2019-12-27 | 2020-02-26 | 30,000 | — | $0 | 158,383 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2019-12-27 | 2020-02-26 | 8,080 | — | $0 | 2,309 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2019-12-27 | 2020-02-26 | 30,000 | $5.12 | $153.6K | 873,519 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2019-12-27 | 2020-02-26 | 8,080 | $3.20 | $25.9K | 843,519 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-20 | 2019-12-20 | 1,400 | $62.64 | $87.7K | 946,319 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-20 | 2019-12-20 | 8,500 | $63.42 | $539.1K | 937,819 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-20 | 2019-12-20 | 1,600 | $63.99 | $102.4K | 936,219 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-19 | 2019-12-20 | 1,400 | $59.84 | $83.8K | 964,819 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-19 | 2019-12-20 | 9,230 | $60.69 | $560.2K | 955,589 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-19 | 2019-12-20 | 4,970 | $61.48 | $305.6K | 950,619 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-19 | 2019-12-20 | 2,900 | $62.33 | $180.8K | 947,719 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-18 | 2019-12-20 | 3,070 | $60.38 | $185.4K | 966,219 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-18 | 2019-12-20 | 7,802 | $59.78 | $466.4K | 969,289 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-18 | 2019-12-20 | 3,730 | $57.76 | $215.4K | 980,989 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-18 | 2019-12-20 | 3,898 | $58.48 | $228.0K | 977,091 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-17 | 2019-12-17 | 3,600 | $60.30 | $217.1K | 999,619 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-17 | 2019-12-17 | 8,100 | $61.13 | $495.2K | 991,519 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-17 | 2019-12-17 | 6,495 | $62.05 | $403.0K | 985,024 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-17 | 2019-12-17 | 305 | $62.71 | $19.1K | 984,719 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-16 | 2019-12-17 | 1,300 | $57.59 | $74.9K | 1,010,819 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-16 | 2019-12-17 | 2,000 | $56.84 | $113.7K | 1,012,119 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-16 | 2019-12-17 | 600 | $55.45 | $33.3K | 1,014,119 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-16 | 2019-12-17 | 2,400 | $59.76 | $143.4K | 1,003,419 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-16 | 2019-12-17 | 200 | $60.43 | $12.1K | 1,003,219 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-16 | 2019-12-17 | 5,000 | $58.75 | $293.8K | 1,005,819 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-13 | 2019-12-17 | 600 | $56.95 | $34.2K | 1,014,719 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-13 | 2019-12-17 | 3,800 | $56.17 | $213.4K | 1,015,319 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-13 | 2019-12-17 | 7,100 | $55.43 | $393.6K | 1,019,119 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-12 | 2019-12-12 | 500 | $53.18 | $26.6K | 1,037,219 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-12 | 2019-12-12 | 10,900 | $54.15 | $590.2K | 1,026,319 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-12 | 2019-12-12 | 100 | $54.66 | $5.5K | 1,026,219 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-11 | 2019-12-12 | 8,928 | $52.72 | $470.7K | 1,040,291 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-11 | 2019-12-12 | 2,452 | $53.67 | $131.6K | 1,037,839 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-11 | 2019-12-12 | 120 | $54.20 | $6.5K | 1,037,719 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-10 | 2019-12-12 | 2,700 | $53.79 | $145.2K | 1,058,019 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-10 | 2019-12-12 | 100 | $55.51 | $5.6K | 1,049,219 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-10 | 2019-12-12 | 8,700 | $54.81 | $476.8K | 1,049,319 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-09 | 2019-12-09 | 4,200 | $55.94 | $234.9K | 1,060,919 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-09 | 2019-12-09 | 200 | $56.78 | $11.4K | 1,060,719 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-09 | 2019-12-09 | 4,100 | $55.35 | $226.9K | 1,065,119 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-09 | 2019-12-09 | 3,000 | $54.33 | $163.0K | 1,069,219 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-06 | 2019-12-09 | 36,627 | $50.67 | $1.86M | 1,086,482 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-06 | 2019-12-09 | 14,263 | $51.02 | $727.7K | 1,072,219 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-05 | 2019-12-09 | 21,280 | $50.93 | $1.08M | 1,157,939 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-05 | 2019-12-09 | 12,200 | $52.08 | $635.4K | 1,145,739 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2019-12-05 | 2019-12-09 | 22,630 | $52.84 | $1.20M | 1,123,109 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2019-06-27 | 2020-02-26 | 54,220 | — | $0 | 188,383 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2019-06-27 | 2020-02-26 | 54,220 | $5.12 | $277.6K | 835,439 | SEC↗ |